CCHN

Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update

Retrieved on: 
Mercoledì, Marzo 20, 2024
Joint venture, Patient, Sale, Business analyst, CCHN, IP, Marketing, Research, Mallinckrodt, Absorption, European Economic Area, Gross metropolitan product, Webcast, Asset, Alvogen, Denosumab, Neovascularization, Biosimilar, Macular degeneration, Safety, Food, U.S. FDA, Teva Pharmaceuticals, Revenue, Q3, CES, AMD, FDA, ISK, Administration, Adalimumab, Research and development, Pharmaceutical industry

Management will conduct a business update conference all and live webcast on March 21, 2024 at 8:00 am ET (12:00 pm GMT).

Key Points: 
  • Management will conduct a business update conference all and live webcast on March 21, 2024 at 8:00 am ET (12:00 pm GMT).
  • Alvotech announced positive top-line results from a pharmacokinetic (PK) study for AVT05, a biosimilar candidate to Simponi® and Simponi Aria® (golimumab).
  • Alvotech announced positive top-line results from a PK study for AVT03, a biosimilar candidate to Prolia® and Xgeva®, which both contain denosumab.
  • Alvotech will conduct a business update conference call and live webcast on Thursday, March 21, 2024, at 8:00 am ET (12:00 pm GMT).

CompleteCare Health Network Provides Notice of Cybersecurity Incident

Retrieved on: 
Sabato, Dicembre 16, 2023
Holiday, POR, Computer, Name, CCHN, PII, Online shopping

BRIDGETON, N.J., Dec. 15, 2023 /PRNewswire/ -- CompleteCare Health Network (CCHN) is providing notice of a recent cybersecurity incident that involved certain individuals' personal identifiable information and personal health information.

Key Points: 
  • GRACIAS
    BRIDGETON, N.J., Dec. 15, 2023 /PRNewswire/ -- CompleteCare Health Network (CCHN) is providing notice of a recent cybersecurity incident that involved certain individuals' personal identifiable information and personal health information.
  • CCHN's investigation determined that the unauthorized third party may have exfiltrated personal data during this incident.
  • The impacted data varied by individual, but it may have contained personal information, including names, phone numbers, addresses, and some sensitive personal information and/or personal health information.
  • We value the security of the data we maintain and are taking steps intended to prevent an incident like this from reoccurring.